18 major players in the global spine biologics market

Written by Shayna Korol | August 09, 2018 | Print  |

The global spine biologics market is predicted to reach $2.7 billion by 2024, growing at a 4.4 percent compound annual growth rate, according to a Data Bridge Market Research report.

Here are 18 major market players:

1. Arthrex

2. Cesca Therapeutics

3. DePuy Synthes

4. DMP Spine

5. Exactech

6. K2M

7. Lattice Biologics

8. Medtronic

9. Nuo Therapeutics

10. Nutech

11. NuVasive

12. Orthofix

13. Regen Lab

14. RTI Surgical

15. Stryker

16. Wright Medical

17. X-Spine Systems

18. Zimmer Holdings

More articles on biologics:
Crocodiles may be the future of cartilage repair — 4 things to know about a new technology
UC San Diego scientists derive spinal cord stem cells: 4 insights
Dr. Kevin Pauza certifies 14 spine physicians in Discseel procedure

© Copyright ASC COMMUNICATIONS 2018. Interested in LINKING to or REPRINTING this content? View our policies here.